Table 1.
Sample Characteristics
| AET n = 44 (48.4 %) (n/mean ± SD) |
FSBT n = 47 (51.6 %) (n/mean ± SD) |
||
|---|---|---|---|
| Study site | pfisher = 0.814 | ||
| Munich | 30 (68.2 %) | 30 (63.8 %) | |
| Mannheim | 10 (22.7 %) | 13 (27.7 %) | |
| Berlin | 4 (9.1 %) | 3 (6.4 %) | |
| Aachen | 0 (0.0 %) | 1 (2.1 %) | |
| Sex | pfisher = 0.268 | ||
| Female | 12 (27.3 %) | 19 (40.4 %) | |
| Male | 32 (72.7 %) | 28 (59.6 %) | |
| Age (years) | 34.55 ± 11.15 | 39.30 ± 12.07 | pwilcox = 0.063 |
| PANSS at baseline (t0) | |||
| Positive scale | 11.18 ± 3.60 | 11.57 ± 4.04 | pwilcox = 0.761 |
| Negative scale | 13.23 ± 5.64 | 11.79 ± 3.59 | pwilcox = 0.420 |
| General scale | 24.89 ± 5.63 | 25.74 ± 5.70 | pwilcox = 0.559 |
| Total scale | 49.30 ± 12.20 | 49.12 ± 10.83 | pwilcox = 1.000 |
| Chlorpromazine equivalents | 458.18 ± 261.44 | 481.68 ± 322.16 | pwilcox = 0.937 |
| Education (years) | 14.68 ± 3.62 | 14.74 ± 4.60 | pwilcox = 0.590 |
| Total number of trainings | 25.73 ± 17.84 | 26.55 ± 21.25 | pwilcox = 0.883 |
| Participants per session | |||
| Baseline (t0) | 44 (100 %) | 47 (100 %) | — |
| After 6 months (t6) | 12 (27.3 %) | 21 (44.7 %) | — |
Descriptive statistics are expressed as mean ± standard deviation. The sample sizes per group refer to the number of participants that were considered for the statistical data analysis. Chlorpromazine equivalents were computed according to the Defined Daily Doses method. AET, aerobic endurance training; FSBT, flexibility, strengthening, and balance training; PANSS, Positive and Negative Syndrome Scale; pfisher, P-value of Fisher´s exact test for categorical data; pwilcox, P-value of Wilcoxon signed-rank test for numeric data; SD, standard deviation.